Patent Yard Sign in
Canadian application, no grantCanada

Adam polynucleotides and polypeptides

CA 2373638 A1 · Owner: Hastings, Gregg A. · Inventors: Shi, Yanggu; Hastings, Gregg A.; Wei, Ping

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to novel human ADAM polypeptides and isolated nucleic acids containing the coding regions of the genes encoding such polypeptides. Also provided are vectors host cells, antibodies, and , recombinant methods for producing human ADAM polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human ADAM polypeptides.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 25, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 25, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 25, 2000
GrantedNo grant recorded
Term endedMay 25, 2020
Patent numberCA 2373638 A1
Classification (IPC)C12N9/64 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMay 25, 2000Term endedMay 25, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.